SLC6A3 and Parkinson disease: Rahmim et al. analyzed cross-sectional data from Parkinson's Progressive Marker Initiative (PPMI) and found that striatal dopamine transporter (DAT) single-photon emission computed tomography (SPECT) textural features significantly correlated with the cognitive and motor status of 85 PD patients (24).